Role of host's transfer RNA import in Plasmodium development

La protéine tRip de Plasmodium, l’agent du paludisme, fait l’objet de mon travail de thèse. Identifiée au laboratoire, elle est localisée à la membrane plasmique de P. berghei, le modèle murin étudié in vivo. Elle permet l’import d’ARNt exogènes à l’intérieur du parasite. La génération et l’étude d’une souche P. berghei tRip-KO m’ont permis d’explorer l’importance de ce mécanisme et l’implication de tRip dans un complexe multiprotéique. J’ai démontré que la multiplication de P. berghei est très réduite lors du stade sanguin chez la souche tRip-KO. Par protéomique, j’ai montré qu’en l’absence de tRip, de nombreuses protéines sont sous-exprimées, en particulier celles riches en asparagines. Enfin, j’ai identifié trois partenaires protéiques de tRip, dont le substrat est l’ARNt. Ces résultats suggèrent que les ARNt importés par Plasmodium via tRip pourraient être substrat de protéines plasmodiales et acteurs de la synthèse protéique du parasite. Le transport d’ARNt étrangers dans une cellule est un mécanisme inconnu en dehors de cette étude. Il révèle une interaction inédite entre un hôte et son parasite intracellulaire, propice au développement de ce dernier.The organism studied in this work is Plasmodium, the malaria parasite. The laboratory identified a membrane protein, called tRip for tRNA import protein, displaying a tRNA binding domain exposed outside of the parasite. In vivo, in P. berghei which is the murine model used, tRip mediates the import of exogenous tRNAs into the parasite cytosol. My PhD work begun with the construction of a tRip-KO strain of P. berghei to investigate the role of tRNA import and the putative involvement of tRip within a proteic complex. The phenotype of the tRip-KO strain is significantly modified compared to the wild-type parasite during the blood stage: its rate of multiplication is much lower. By proteomic analyses, I showed that many proteins are under-regulated in the tRip-KO strain, especially those very rich in asparagines. Moreover, I dentified three protein partners for tRip, being tRNA aminoacylation or modification enzymes. These results suggest that host imported tRNAs could be taken in charge by parasitic enzymes and take part to Plasmodium protein synthesis. This work reveals a new host pathogen interaction and is the first example showing exogenous tRNA import into a cell

Rôle de l'import des ARN de transfert de l'hôte dans le développement Plasmodium

The organism studied in this work is Plasmodium, the malaria parasite. The laboratory identified a membrane protein, called tRip for tRNA import protein, displaying a tRNA binding domain exposed outside of the parasite. In vivo, in P. berghei which is the murine model used, tRip mediates the import of exogenous tRNAs into the parasite cytosol. My PhD work begun with the construction of a tRip-KO strain of P. berghei to investigate the role of tRNA import and the putative involvement of tRip within a proteic complex. The phenotype of the tRip-KO strain is significantly modified compared to the wild-type parasite during the blood stage: its rate of multiplication is much lower. By proteomic analyses, I showed that many proteins are under-regulated in the tRip-KO strain, especially those very rich in asparagines. Moreover, I dentified three protein partners for tRip, being tRNA aminoacylation or modification enzymes. These results suggest that host imported tRNAs could be taken in charge by parasitic enzymes and take part to Plasmodium protein synthesis. This work reveals a new host pathogen interaction and is the first example showing exogenous tRNA import into a cell.La protéine tRip de Plasmodium, l’agent du paludisme, fait l’objet de mon travail de thèse. Identifiée au laboratoire, elle est localisée à la membrane plasmique de P. berghei, le modèle murin étudié in vivo. Elle permet l’import d’ARNt exogènes à l’intérieur du parasite. La génération et l’étude d’une souche P. berghei tRip-KO m’ont permis d’explorer l’importance de ce mécanisme et l’implication de tRip dans un complexe multiprotéique. J’ai démontré que la multiplication de P. berghei est très réduite lors du stade sanguin chez la souche tRip-KO. Par protéomique, j’ai montré qu’en l’absence de tRip, de nombreuses protéines sont sous-exprimées, en particulier celles riches en asparagines. Enfin, j’ai identifié trois partenaires protéiques de tRip, dont le substrat est l’ARNt. Ces résultats suggèrent que les ARNt importés par Plasmodium via tRip pourraient être substrat de protéines plasmodiales et acteurs de la synthèse protéique du parasite. Le transport d’ARNt étrangers dans une cellule est un mécanisme inconnu en dehors de cette étude. Il révèle une interaction inédite entre un hôte et son parasite intracellulaire, propice au développement de ce dernier

Discovery of two distinct aminoacyl-tRNA synthetase complexes anchored to the Plasmodium surface tRNA import protein

Aminoacyl-tRNA synthetases (aaRSs) attach amino acids to their cognate transfer RNAs. In eukaryotes, a subset of cytosolic aaRSs is organized into a multisynthetase complex (MSC), along with specialized scaffolding proteins referred to as aaRS-interacting multifunctional proteins (AIMPs). In Plasmodium, the causative agent of malaria, the tRNA import protein (tRip), is a membrane protein that participates in tRNA trafficking; we show that tRip also functions as an AIMP. We identified three aaRSs, the glutamyl-tRNA synthetase (ERS), glutaminyl-tRNA synthetase (QRS), and methionyl-tRNA synthetase (MRS), which were specifically coimmunoprecipitated with tRip in Plasmodium berghei blood stage parasites. All four proteins contain an N-terminal glutathione-S-transferase (GST)-like domain that was demonstrated to be involved in MSC assembly. In contrast to previous studies, further dissection of GST-like interactions identified two exclusive heterotrimeric complexes: the Q-complex (tRip-ERS-QRS) and the M-complex (tRip-ERS-MRS). Gel filtration and light scattering suggest a 2:2:2 stoichiometry for both complexes but with distinct biophysical properties and mutational analysis further revealed that the GST-like domains of QRS and MRS use different strategies to bind ERS. Taken together, our results demonstrate that neither the singular homodimerization of tRip nor its localization in the parasite plasma membrane prevents the formation of MSCs in Plasmodium. Besides, the extracellular localization of the tRNA-binding module of tRip is compensated by the presence of additional tRNA-binding modules fused to MRS and QRS, providing each MSC with two spatially distinct functions: aminoacylation of intraparasitic tRNAs and binding of extracellular tRNAs. This unique host-pathogen interaction is discussed

OB or Not OB: Idiosyncratic utilization of the tRNA-binding OB-fold domain in unicellular, pathogenic eukaryotes

International audienc

Apicomplexa -specific tRip facilitates import of exogenous tRNAs into malaria parasites

International audienc

Identification of Borrelia protein candidates in mouse skin for potential diagnosis of disseminated Lyme borreliosis

Abstract In vector-borne diseases, the skin plays an essential role in the transmission of vector-borne pathogens between the vertebrate host and blood-feeding arthropods and in pathogen persistence. Borrelia burgdorferi sensu lato is a tick-borne bacterium that causes Lyme borreliosis (LB) in humans. This pathogen may establish a long-lasting infection in its natural vertebrate host where it can persist in the skin and some other organs. Using a mouse model, we demonstrate that Borrelia targets the skin regardless of the route of inoculation, and can persist there at low densities that are difficult to detect via qPCR, but that were infective for blood-feeding ticks. Application of immunosuppressive dermocorticoids at 40 days post-infection (PI) significantly enhanced the Borrelia population size in the mouse skin. We used non-targeted (Ge-LC-MS/MS) and targeted (SRM-MS) proteomics to detect several Borrelia-specific proteins in the mouse skin at 40 days PI. Detected Borrelia proteins included flagellin, VlsE and GAPDH. An important problem in LB is the lack of diagnosis methods capable of detecting active infection in humans suffering from disseminated LB. The identification of Borrelia proteins in skin biopsies may provide new approaches for assessing active infection in disseminated manifestations

A novel HERC4-dependent glue degrader targeting STING

Stimulator of interferon genes (STING) is a central component of the pathway sensing the presence of cytosolic nucleic acids, having a key role in type I interferon innate immune response. Localized at the endoplasmic reticulum (ER), STING becomes activated by cGAMP, which is generated by the intracellular DNA sensor cyclic GMP-AMP synthase (cGAS). Due to its critical role in physiological function and its’ involvement in a variety of diseases, STING has been a notable focus for drug discovery. Recent advances in drug discovery allow the targeting of proteins previously considered “un-druggable” by novel mechanism of actions. Molecular glue degraders are defined as the compounds leading targeted protein degradation (TPD) by creating novel ligase-substrate interactions. Here, we identified AK59 as a novel molecular glue degrader for STING. A genome-wide, CRISPR/Cas9 knockout screen showed that the compound-mediated degradation of STING by AK59 is compromised by the loss of HECT and RLD domain containing E3 ubiquitin protein ligase 4 (HERC4), ubiquitin-like modifier activating enzyme 5 (UBA5) and ubiquitin like modifier activating enzyme 6 (UBA6). While UBA5 and UBA6 could be the auxiliary factors for AK59 activity, our results indicate that HERC4 is the main E3 ligase for the observed degradation mechanism. Validation by individual CRISPR knockouts, co-immunoprecipitations, as well as proximity mediated reporter assays suggested that AK59 functions as a glue degrader by forming a novel interaction between STING and HERC4. Furthermore, our data reveals that AK59 was effective on the most common pathological STING mutations that cause STING-associated vasculopathy with onset in infancy (SAVI), suggesting a potential clinical application of this mechanism. Thus, these findings not only reveal a novel mechanism for compound-induced degradation of STING but also utilize HERC4 as potential E3 ligase that for TPD, enabling novel therapeutic applications